|
RWDD3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.851500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.583400E-01 |
| Normal-vs-Stage2 |
2.148000E-01 |
| Normal-vs-Stage3 |
8.495600E-01 |
| Normal-vs-Stage4 |
7.338000E-02 |
| Stage1-vs-Stage2 |
3.870600E-01 |
| Stage1-vs-Stage3 |
4.202600E-01 |
| Stage1-vs-Stage4 |
2.422600E-01 |
| Stage2-vs-Stage3 |
2.671200E-01 |
| Stage2-vs-Stage4 |
8.981400E-01 |
| Stage3-vs-Stage4 |
1.959220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.821500E-02 |
| Normal-vs-AfricanAmerican |
1.654580E-01 |
| Normal-vs-Asian |
2.169600E-02 |
| Caucasian-vs-AfricanAmerican |
9.546800E-01 |
| Caucasian-vs-Asian |
1.828600E-01 |
| AfricanAmerican-vs-Asian |
2.881000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.060400E-01 |
| Normal-vs-Female |
7.204700E-03 |
| Male-vs-Female |
1.760350E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.032800E-01 |
| Normal-vs-Extreme_Weight |
2.719000E-01 |
| Normal-vs-Obese |
4.830200E-01 |
| Normal-vs-Extreme_Obese |
1.494170E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.297600E-01 |
| Normal_Weight-vs-Obese |
3.368600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.635600E-01 |
| Extreme_Weight-vs-Obese |
6.909400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.507200E-01 |
| Obese-vs-Extreme_Obese |
2.154600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.775300E-03 |
| Normal-vs-Age(41-60Yrs) |
1.395600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.469030E-01 |
| Normal-vs-Age(81-100Yrs) |
5.013000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.602300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.080160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.795200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.946800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.127180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.225800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.974100E-02 |
| Normal-VS-Type2 PRCC |
5.416800E-01 |
| Normal-VS-KIRP CIMP |
4.809000E-01 |
| Normal-VS-Unclassified PRCC |
1.773990E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.169600E-04 |
| Type1 PRCC-VS-KIRP CIMP |
4.816800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.478800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.950560E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.805600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.134000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.875000E-01 |
| Normal-vs-N1 |
8.613500E-02 |
| Normal-vs-N2 |
7.646800E-01 |
| N0-vs-N1 |
2.674800E-01 |
| N0-vs-N2 |
7.430600E-01 |
| N1-vs-N2 |
8.730200E-01 |
|
|
